From Challenge to Victory: TFS’s RWE EMA Success Story with a Pivotal Retrospective Study
Download our case study to:
Delve into how TFS leveraged vast US real-world data to secure EMA approval for an extended-release CNS drug, bypassing traditional costly trials.
Witness how our RWE team’s innovative design and AI-assisted analyses cut costs by 30 times and accelerated timelines, achieving non-inferiority and even superiority in key endpoints. Download now to uncover the RWE-driven breakthroughs that delivered this triumph.
"*" indicates required fields